Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Kronos Bio Q3 EPS $(0.61) Up From $(6.48) YoY

Kronos Bio (NASDAQ:KRON) reported quarterly losses of $(0.61) per share. This is a 90.59 percent increase over losses of $(6.48) per share from the same period last year.
byBenzinga Newsdesk
November 9, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Kronos Bio (NASDAQ:KRON) reported quarterly losses of $(0.61) per share. This is a 90.59 percent increase over losses of $(6.48) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

This Week’s Scheduled IPOs

By Benzinga Insights
Today, 3:20 AM
With the start of a new week comes the excitement surrounding a new set of companies looking to make an impact through their public offerings. According to Benzinga Pro, here's the company scheduled to begin trading publicly this week.

VRAX